CENCORA INC (COR)

US03073E1055 - Common Stock

223.95  -0.79 (-0.35%)

After market: 223.95 0 (0%)

Fundamental Rating

6

Taking everything into account, COR scores 6 out of 10 in our fundamental rating. COR was compared to 118 industry peers in the Health Care Providers & Services industry. While COR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. COR has a correct valuation and a medium growth rate.



7

1. Profitability

1.1 Basic Checks

In the past year COR was profitable.
COR had a positive operating cash flow in the past year.
COR had positive earnings in 4 of the past 5 years.
COR had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

COR's Return On Assets of 2.90% is fine compared to the rest of the industry. COR outperforms 70.09% of its industry peers.
COR's Return On Equity of 151.04% is amongst the best of the industry. COR outperforms 99.15% of its industry peers.
COR has a better Return On Invested Capital (15.56%) than 93.16% of its industry peers.
COR had an Average Return On Invested Capital over the past 3 years of 14.75%. This is significantly above the industry average of 8.58%.
The 3 year average ROIC (14.75%) for COR is below the current ROIC(15.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.9%
ROE 151.04%
ROIC 15.56%
ROA(3y)2.83%
ROA(5y)0.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.75%
ROIC(5y)14.93%

1.3 Margins

COR has a better Profit Margin (0.67%) than 62.39% of its industry peers.
In the last couple of years the Profit Margin of COR has declined.
COR has a Operating Margin (1.01%) which is in line with its industry peers.
COR's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 3.39%, COR is not doing good in the industry: 82.91% of the companies in the same industry are doing better.
COR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.01%
PM (TTM) 0.67%
GM 3.39%
OM growth 3Y-3.22%
OM growth 5Y-1.19%
PM growth 3YN/A
PM growth 5Y-7.58%
GM growth 3Y7.17%
GM growth 5Y3.95%

4

2. Health

2.1 Basic Checks

COR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
COR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, COR has less shares outstanding
Compared to 1 year ago, COR has an improved debt to assets ratio.

2.2 Solvency

COR has a debt to FCF ratio of 2.49. This is a good value and a sign of high solvency as COR would need 2.49 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.49, COR belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
COR has a Debt/Equity ratio of 3.41. This is a high value indicating a heavy dependency on external financing.
COR's Debt to Equity ratio of 3.41 is on the low side compared to the rest of the industry. COR is outperformed by 72.65% of its industry peers.
Although COR does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 3.41
Debt/FCF 2.49
Altman-Z N/A
ROIC/WACC1.79
WACC8.68%

2.3 Liquidity

COR has a Current Ratio of 0.89. This is a bad value and indicates that COR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.89, COR is doing worse than 76.07% of the companies in the same industry.
COR has a Quick Ratio of 0.89. This is a bad value and indicates that COR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.53, COR is doing worse than 84.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.53

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.51% over the past year.
COR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.03% yearly.
Looking at the last year, COR shows a quite strong growth in Revenue. The Revenue has grown by 11.71% in the last year.
The Revenue has been growing by 9.32% on average over the past years. This is quite good.
EPS 1Y (TTM)12.51%
EPS 3Y14.92%
EPS 5Y13.03%
EPS growth Q2Q8.57%
Revenue 1Y (TTM)11.71%
Revenue growth 3Y11.35%
Revenue growth 5Y9.32%
Revenue growth Q2Q7.81%

3.2 Future

COR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.03% yearly.
The Revenue is expected to grow by 7.54% on average over the next years.
EPS Next Y13.28%
EPS Next 2Y10.86%
EPS Next 3Y10.34%
EPS Next 5Y11.03%
Revenue Next Year12.43%
Revenue Next 2Y9.37%
Revenue Next 3Y8.04%
Revenue Next 5Y7.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

COR is valuated rather expensively with a Price/Earnings ratio of 17.41.
78.63% of the companies in the same industry are more expensive than COR, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.73, COR is valued a bit cheaper.
A Price/Forward Earnings ratio of 15.20 indicates a correct valuation of COR.
Based on the Price/Forward Earnings ratio, COR is valued a bit cheaper than 76.07% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.41. COR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.41
Fwd PE 15.2

4.2 Price Multiples

COR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. COR is cheaper than 69.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COR indicates a somewhat cheap valuation: COR is cheaper than 75.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.16
EV/EBITDA 12.64

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of COR may justify a higher PE ratio.
PEG (NY)1.31
PEG (5Y)1.34
EPS Next 2Y10.86%
EPS Next 3Y10.34%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.91%, COR is not a good candidate for dividend investing.
COR's Dividend Yield is rather good when compared to the industry average which is at 2.74. COR pays more dividend than 83.76% of the companies in the same industry.
With a Dividend Yield of 0.91, COR pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of COR has a limited annual growth rate of 4.87%.
COR has been paying a dividend for at least 10 years, so it has a reliable track record.
COR has decreased its dividend recently.
Dividend Growth(5Y)4.87%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

COR pays out 22.12% of its income as dividend. This is a sustainable payout ratio.
The dividend of COR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.12%
EPS Next 2Y10.86%
EPS Next 3Y10.34%

CENCORA INC

NYSE:COR (5/3/2024, 7:04:00 PM)

After market: 223.95 0 (0%)

223.95

-0.79 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap44.67B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 17.41
Fwd PE 15.2
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.31
PEG (5Y)1.34
Profitability
Industry RankSector Rank
ROA 2.9%
ROE 151.04%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.01%
PM (TTM) 0.67%
GM 3.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover4.33
Health
Industry RankSector Rank
Debt/Equity 3.41
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.89
Quick Ratio 0.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)12.51%
EPS 3Y14.92%
EPS 5Y
EPS growth Q2Q
EPS Next Y13.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.71%
Revenue growth 3Y11.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y